000002994 001__ 2994
000002994 005__ 20250424232808.0
000002994 0247_ $$2DOI$$a10.6083/M4CV4GTX
000002994 037__ $$aETD
000002994 245__ $$aIdentifying barriers in the implementation of a harm reduction program for opiate overdose
000002994 260__ $$bOregon Health and Science University
000002994 269__ $$a2016-07-01
000002994 336__ $$aPortfolio
000002994 502__ $$bPh.D.
000002994 520__ $$aPrescription opiate overdose is a leading cause of death among adults in the United States. If prescription opiates are the causative factor for multiple drug overdoses each year, then it would follow that naloxone needs to be distributed to both IV drug users and to prescription opiate users. However, while multiple organizations, including SAMHSA, now promote co-prescribing models  (wherein naloxone is consistently prescribed with all opiates), and consider it to be best practice, there are often significant barriers to implementing this practice.
000002994 650__ $$aOpioid-Related Disorders$$022689
000002994 650__ $$aNaloxone$$022667
000002994 650__ $$aOpiate Overdose$$013377
000002994 650__ $$aDrug Users$$038136
000002994 650__ $$aCause of Death$$016248
000002994 650__ $$aDrug Prescriptions$$024578
000002994 691__ $$aSchool of Nursing$$041370
000002994 7001_ $$aBartholow, Lydia$$uOregon Health and Science University$$041354
000002994 7201_ $$aScharf, Margaret$$uOregon Health and Science University$$041354$$7Personal$$eAdvisor
000002994 8564_ $$98c9f89b1-0c30-4391-bbc5-19835e5c00d1$$s142988$$uhttps://digitalcollections.ohsu.edu/record/2994/files/3797_etd.pdf$$ePublic$$25bb92bad3bc8f1bf55567f4526b5ad0c$$31
000002994 905__ $$a/rest/prod/86/23/hx/96/8623hx969
000002994 909CO $$ooai:digitalcollections.ohsu.edu:2994$$pstudent-work
000002994 980__ $$aTheses and Dissertations